Related by context. All words. (Click for frequent words.) 81 serum phosphorous 72 urine albumin 71 glomerular filtration rate 71 BENICAR HCT 70 relapsed MM 70 serum potassium 70 Pharmacokinetic parameters 69 serum aminotransferase levels 69 Primary endpoints 69 #.#mg/dL 69 Fasting blood glucose 69 fasting plasma glucose FPG 68 aspartate aminotransferase AST 68 alanine aminotransferase ALT 68 microalbumin 68 serum lipid levels 68 estimated glomerular filtration 68 glycosylated hemoglobin HbA1c 68 serum phosphate 68 hematological parameters 68 corticosteroid dose 68 AST ALT 67 exhaled nitric oxide 67 glomerular filtration 67 CrCl 67 Cystatin C 67 activated partial thromboplastin 67 glycated hemoglobin levels 67 SGPT 67 Skin sterol 67 Index CDAI 67 mL/min/#.# m 2 67 morphometric vertebral fractures 67 hemoglobin A1c HbA1c 67 BENICAR 67 specific antigen PSA 67 glycated hemoglobin HbA1c 67 serum leptin 67 See CLINICAL PHARMACOLOGY 67 serum electrolytes 67 serum cortisol 67 urine cytology 66 Cardiorespiratory fitness 66 OGTT 66 PRADAXA #mg 66 Hb A1C 66 CK # plasma concentrations 66 irbesartan 66 serum calcium 66 oxycodone CR 66 ATACAND 66 statin monotherapy 66 hypophosphatemia 66 creatinine clearance 66 baseline HbA1c 66 QTc prolongation 66 elevated ALT 66 serum urate 66 Ejection Fraction 66 serum uric acid 66 Tumor Response 66 Proteinuria 66 HBeAg seroconversion 66 postintervention 66 elevated serum creatinine 66 aminotransferases 66 coronary arteriography 66 urinary albumin 66 CIMZIA ™ 66 natriuresis 66 PSA nadir 66 pulmonary capillary wedge 66 hemoglobin A1c levels 66 serum creatinine levels 66 hepatic function 66 albumin excretion rate 66 mL/min/#.# m2 66 oral antidiabetic medication 66 fosamprenavir 66 iPTH 66 -#.# log# 66 #.#/#.# mmHg [001] 65 Secondary efficacy endpoints 65 Hematocrit 65 aminotransferase ALT 65 fraction LVEF 65 microalbumin test 65 aspartate aminotransferase 65 sUA 65 alanine aminotransferase 65 cTnI 65 bronchial hyperresponsiveness 65 Hypotension 65 Mg Usa 65 Viral load 65 Crohn Disease Activity 65 ritonavir boosted 65 mg BID dose 65 Postoperative complications 65 bronchoalveolar lavage 65 serum HBV DNA 65 hyperphenylalaninemia HPA due 65 antibody titer 65 Ranolazine 65 serum HCV RNA 65 HbA1C 65 spirometric 65 TURBT 65 PASI scores 65 mild renal insufficiency 65 urinary N telopeptide 65 β blockers 65 HER2 expression 65 serum triglycerides 65 HbA 1c 65 protein excretion 65 creatinine ratio 65 serum calcium levels 65 creatinine levels 65 APTIVUS r 65 STRIDE PD 65 biochemical relapse 65 transcranial Doppler ultrasound 65 exhaled NO 64 CHAMPION PCI 64 Hemoglobin A1c 64 Alkaline Phosphatase 64 atrioventricular block 64 baseline serum creatinine 64 upper endoscopy 64 reduce serum phosphate 64 rosuvastatin #mg 64 hepatic enzyme 64 urinary protein 64 hemoglobin A1C 64 hemoglobin A1C HbA1C 64 Levels Linked 64 plasma cortisol 64 blood counts CBCs 64 hemoglobin Hb 64 SGOT 64 prednisone prednisolone plus 64 LDL triglycerides 64 PREZISTA r arm 64 lymphocyte count 64 esophageal manometry 64 C Reactive Protein 64 preintervention 64 budesonide pMDI 64 Acetate Rectal Suppositories 64 serum phosphorus 64 alanine transaminase ALT 64 lipoprotein Lp 64 moderate renal impairment 64 8mg/kg 64 mmHg diastolic 64 pharmacokinetic PK profile 64 ULORIC 64 epoetin alpha 64 myeloperoxidase 64 mediated dilation 64 intraobserver 64 serum PSA 64 PROCTOCORT ® Suppository Hydrocortisone 64 PCWP 64 RECIST Response Evaluation Criteria 64 symptomatic VTE 64 mU liter 64 urinary albumin excretion 64 severe renal impairment 64 fluvastatin 64 adenotonsillectomy 64 Secondary endpoints 64 mcg QD 64 OBPM 64 asymptomatic carotid stenosis 64 mucosal healing 64 metabolite concentrations 64 mineral density BMD 64 blood Phe levels 64 β blocker 64 HBV DNA levels 64 glucose insulin 64 Nebulized 64 liver histology 64 hematologic parameters 64 del 5q MDS 64 atazanavir ritonavir 64 left ventricular diastolic 64 HOMA IR 64 CIMZIA TM 64 transrectal ultrasound guided 64 CTAP# Capsules 64 NHANES III 64 thyroid stimulating hormone 64 fasting glucose levels 64 nonfasting triglyceride levels 64 DAS# CRP 63 EDARBI 63 TM carboxyhemoglobin SpCO 63 Ambulatory Blood Pressure 63 aldosterone antagonist 63 tissue oxygenation 63 -#.# mg dL [002] 63 Insulin PH# 63 NATRECOR R 63 HbA 1c levels 63 Secondary endpoints included 63 lopinavir r arm 63 desvenlafaxine succinate 63 lumbar spine bone 63 postoperative mortality 63 biologic DMARD 63 Multivariate analysis 63 zonisamide SR 63 binary restenosis 63 lumbar spine BMD 63 nicardipine 63 D Dimer 63 abdominal computed tomography 63 fasting plasma glucose 63 Echocardiographic 63 #mg/day [002] 63 IV bolus 63 culture supernatants 63 Platelet counts 63 intravascular hemolysis 63 lactate dehydrogenase LDH 63 dosing cohort 63 NIASPAN 63 posttreatment 63 azilsartan medoxomil 63 unfractionated heparin UFH 63 statistical significance p 63 serum glucose 63 aPTT 63 esophagogastroduodenoscopy 63 fasting serum 63 PSADT 63 inotropic 63 Adenomas 63 myocardial viability 63 unstable angina pectoris 63 Microalbuminuria 63 PLX STROKE targeting 63 HDL Cholesterol 63 echocardiographic parameters 63 coadministration 63 maternal serum 63 CYP#A# CYP#D# 63 ARB telmisartan 63 certolizumab 63 hsCRP levels 63 steroid dexamethasone 63 basal bolus regimen 63 erosive gastritis 63 serum testosterone 63 HCV RESPOND 2 63 atherogenic dyslipidemia 63 procalcitonin 63 oral rivaroxaban 63 fasting triglycerides 63 Glomerular Filtration Rate 63 glycated hemoglobin 63 CK MB 63 ug kg 63 neutrophil counts 63 NPH insulin 63 CIMZIA TM certolizumab pegol 63 cardiac perfusion 63 plasma triglycerides 63 4mg/kg 63 Solid Tumors criteria 63 dose escalation phase 63 -#.# log# copies mL 63 Secondary endpoints include 63 #.#ng/ml 63 Tasigna prolongs 63 postprocedure 63 serum thyroglobulin 63 test OGTT 63 Known hypersensitivity 63 Albuminuria 63 plasma lipids 63 moderate hepatic impairment 63 IFN α 63 Events MACE 63 hemostatic efficacy 63 Lp PLA 2 63 trough FEV1 63 glycosylated hemoglobin 63 triiodothyronine 63 urinary calcium excretion 63 serum lipid 63 apolipoprotein B 63 highly emetogenic 63 postdose 63 pulmonary arterial 63 BYSTOLIC 63 oral glucose tolerance 63 myopathy rhabdomyolysis 63 By JENNIFER LEARN 63 HES CEL 63 Am J Cardiol 63 overt nephropathy 63 Hypertrophy 63 MULTAQ 63 colorectal adenoma 63 lipid parameters 63 fasting blood glucose 62 mg/m2 dose 62 tuberculin skin testing 62 NovoLog ® Mix 62 lispro 62 SpO 2 62 μg dL 62 ARIXTRA 62 LV ejection fraction 62 transient elastography 62 International Prostate Symptom 62 transaminases 62 anaphylactic reactions bronchospasm 62 glycosylated hemoglobin levels 62 candesartan cilexetil 62 chest radiographs 62 serum phosphate levels 62 serum concentrations 62 XIENCE V PROMUS Stent 62 SpCO 62 ACTEMRA TM 62 Infusion Reactions Severe 62 metabolic parameters 62 Non inferiority 62 hepatic enzymes 62 estimated GFR 62 serum creatinine 62 somatostatin analog 62 conjunctival hyperemia 62 FluCAM arm 62 coronary stenosis 62 N telopeptide 62 Cardiopulmonary bypass 62 angiotensin II receptor blockers 62 permanently discontinue Vectibix 62 cEVR 62 CYP#A# substrate 62 NNT = 62 elevated creatinine 62 hepatectomy 62 Predict Risk 62 tipranavir r 62 benazepril 62 Prostate specific antigen 62 Serum creatinine 62 serum urate levels 62 vaginal hysterectomy 62 hypopneas 62 serum potassium levels 62 serum bilirubin 62 postoperative morbidity 62 achieved ACR# 62 ADCS CGIC 62 #mg #mg #mg [003] 62 umol L 62 Mg Uk 62 troponin T 62 periprocedural 62 HbA1C levels 62 plus methotrexate 62 plasma HCV RNA 62 left ventricular systolic 62 EDSS score 62 metabolic alkalosis 62 Thrombolysis 62 Montgomery Asberg Depression 62 posttransplant 62 posttest 62 myocardial uptake 62 serum bicarbonate 62 diuretics beta blockers 62 carotid IMT 62 elevated LDH 62 elevated transaminases 62 LDL Cholesterol 62 myocardial infarction ventricular fibrillation 62 IOP lowering 62 Myelosuppression 62 FUSILEV enhances 62 hypercalciuria 62 ALT elevation 62 advanced adenoma 62 haematologic 62 prospectively stratified 62 Plaque Psoriasis 62 Brief Psychiatric 62 Hyperlipidemia 62 plasma creatinine 62 onset diabetes mellitus 62 #q# deletion syndrome 62 serum prostate 62 ALT normalization 62 APTIVUS 62 ADCS ADL 62 RAPAFLO R 62 hemodynamic variables 62 dizziness nausea diarrhea 62 cerebral oxygen saturation 62 Tipranavir 62 salmeterol inhalation powder 62 Univariate 62 hepatorenal syndrome 62 colesevelam HCl 62 cytoreductive nephrectomy 62 Subgroup analysis 62 Secondary Hyperparathyroidism 62 insulin detemir 62 oxycodone IR 62 FENO 62 genotypic resistance 62 severe exacerbations 62 HSCT 62 retinal thickness 62 mineral density 62 abacavir lamivudine 62 Angiographic 62 annualized relapse 62 urinary oxalate 62 homocysteine concentrations 62 paraprotein 62 ALT flares 62 LH FSH 62 serum lactate 62 salmeterol fluticasone 62 artery stenosis 62 CYT# potent vascular disrupting 62 Apidra ® 62 COPEGUS therapy 62 serum CRP 62 #mmHg [001] 62 F FDG PET 62 macroalbuminuria 62 fructosamine 62 eosinophil count 62 Psoriasis Area 62 microvessel density 62 HBeAg negative 62 liver biopsies 62 secondary efficacy endpoint 62 apo B 62 intravitreal injections 62 vitreous floaters 62 aminotransferase 62 Fracture Risk 62 Bone Mineral Density 62 #.#mmHg 62 urinary calcium 62 PRADAXA 62 autoantibody levels 62 HBeAg negative patients 62 #.#/#.# mm Hg [003] 62 #mg doses [002] 62 UACR 62 dapagliflozin plus 62 prolonged QT interval 62 inducible nitric oxide synthase 62 malondialdehyde MDA 62 Score IPSS 62 DAS# remission 62 eplerenone 62 riociguat 62 Montgomery Åsberg Depression 62 Chronic HCV 62 Pioglitazone 62 IIIa inhibitor 62 arterial oxygen saturation 62 fasting triglyceride levels 62 serum IGF 61 salivary cortisol 61 MADRS score 61 anti JCV antibodies 61 GAMMAGARD 61 elevated LDL cholesterol 61 ursodeoxycholic acid 61 histopathologic diagnosis 61 QT QTc 61 lispro alone 61 Thiazolidinediones 61 detectable HCV RNA 61 hypokalemia 61 serum sodium 61 fractional shortening 61 virological response 61 albumin creatinine ratio 61 fasting insulin 61 prespecified secondary 61 weekly CSBMs 61 Myocardial Infarction Study 61 NYHA functional class 61 generalized edema 61 pulmonary exacerbations 61 erythrocyte sedimentation rate 61 receiving INTRON 61 thyroglobulin 61 colonoscopy flexible sigmoidoscopy 61 mm Hg diastolic 61 Endothelial function 61 Erythropoietic therapies may 61 CDAI score 61 Naive Patients 61 serum estradiol 61 dose cohort 61 postoperative complication 61 pharmacodynamic parameters 61 intravesical therapy 61 Response Evaluation Criteria 61 systolic dysfunction 61 Patients Receiving 61 #mg/dL [001] 61 EXJADE 61 reinfarction 61 Spinal Fractures 61 dose Iluvien 61 HDL triglycerides 61 Castration Resistant Prostate Cancer 61 EURIDIS 61 triglyceride concentrations 61 abdominal ultrasound 61 fluticasone salmeterol 61 transaminase levels 61 mEq L 61 eosinophilia 61 AZOR 61 CT Angiography 61 IFN alfa 61 preoperative PSA 61 Tiotropium 61 Hypertensive adverse reactions 61 MYCAMINE 61 lactate dehydrogenase 61 brand ciclesonide HFA 61 urinary cortisol 61 Inventory BPI 61 SpO2 pulse rate 61 cTnT 61 transurethral 61 Coronary Artery Bypass Graft 61 K ras mutations 61 serum triglyceride levels 61 undetectable HBV DNA 61 myocardial reperfusion 61 YMRS 61 pelvic lymphadenectomy 61 pericardial effusion 61 QTc 61 intima media thickness 61 COPD exacerbation 61 Cervista HPV HR 61 hip BMD 61 atorvastatin #mg 61 teriflunomide 61 nonfasting triglycerides 61 Hepatotoxicity 61 quetiapine XR 61 paricalcitol 61 hypertrichosis occurred 61 EDEMA3 trial 61 Cytogenetic 61 fibrinolysis 61 CR nPR 61 poor metabolizers 61 Ribavirin causes 61 vascular reactivity 61 pioglitazone HCl 61 LANTUS R 61 mg kg Hematide 61 flow mediated dilation 61 Creatinine 61 linoleic acid LA 61 adjunctive placebo 61 HBeAg positive patients 61 brachial artery flow 61 #mg/dl 61 torsade de pointes 61 Elitek 61 vitamin B# folic acid 61 Fibromyalgia Impact Questionnaire 61 blood Phe 61 NOAEL 61 QTcF 61 concomitant medications 61 CANCIDAS 61 #/#mmHg 61 platelet reactivity 61 Pharmacodynamic 61 eNO 61 HbA 1C 61 FOLPI 61 HDL LDL 61 pathologic examination 61 mmol l 61 corrected QT interval 61 lenalidomide Revlimid R 61 intact parathyroid hormone 61 D dimer 61 Severity MSCS score 61 alfa 2a 61 #mg/day [001] 61 DLTs 61 6 phosphate dehydrogenase 61 Insulin sensitivity 61 intravenous bolus 61 hypercholesterolaemia 61 fasting plasma 61 peak VO2 61 Renal Function 61 evaluable subjects 61 corticosteroid therapy 61 receiving golimumab 61 thoracoscopic lobectomy 61 mg TID 61 cardiovascular hospitalizations 61 bone marrow reticulin 61 tracheal intubation 61 pentoxifylline 61 urinary excretion 61 multivariable analysis 61 CIN2 + 61 methemoglobin 61 receiving VELCADE 61 Warfarin Coumadin 61 Circulating Tumor Cells 61 transurethral resection 61 receiving prophylactic anticoagulation 61 transaminase 61 UPDRS motor 61 ng dL 61 microbiologically evaluable 61 Bronchopulmonary Dysplasia 61 elevated fasting glucose 61 renal biopsy 61 Improves Outcomes 61 fasting glucose 61 cTnT levels 61 detrusor overactivity 61 hydroxyvitamin D levels 61 Prostate Cancer Recurrence 61 included exfoliative dermatitis 61 mcg Albuferon 61 infliximab monotherapy 61 flutamide 61 lipid lowering agents 61 Blood Glucose Testing 61 bivariate analysis 61 arteriography 61 PREZISTA ritonavir 61 NATRECOR ® 61 olmesartan medoxomil hydrochlorothiazide 61 SPRYCEL ® 61 trimethoprim sulfamethoxazole 61 HDL LDL ratio 61 Severe hypoglycemia 61 Phe restricted diet 61 deep venous thromboses 61 urinary sodium excretion 61 Postoperative 61 pg mL 61 endoscopic remission 61 baseline LDH 61 salpingo oophorectomy 61 elevated TSH 61 pyrazinamide 61 cardiac troponin T 61 angiographically 61 tolterodine ER 61 Subarachnoid hemorrhage 61 thromboembolic complications 61 Inhibin B 61 Lantus ® 61 total cholesterol triglycerides 61 luteinising hormone LH 60 NMIBC 60 ARCOXIA 60 NIHSS 60 coagulation abnormalities 60 histologic subtype 60 HIV HCV coinfected 60 digital rectal examination 60 Aggressive Prostate Cancer 60 advanced adenomas 60 #mg/m# [002] 60 albumin excretion 60 ABCB1 60 hypomagnesemia 60 Prognostic Value 60 Left Ventricular 60 neutropenia dehydration dyspnea 60 amoxicillin clavulanate 60 recurrent venous thromboembolism 60 baseline Hb 60 debulking surgery 60 neutropaenia 60 pressure monitoring ABPM 60 systemic corticosteroid 60 neutrophil count 60 Ankle Brachial Index 60 postoperative AF 60 KOMBIGLYZE XR 60 microgram kg 60 tapentadol IR 60 serum ferritin 60 hemodialysis patients 60 LOVENOX R 60 HBsAg 60 bronchial reactivity 60 novel VDA molecule 60 HBV infections 60 liver steatosis 60 Folfox 60 Follicular Lymphoma 60 histological subtype 60 hypoglycemic events 60 Acute Decompensated Heart Failure 60 perioperatively 60 fluoxetine paroxetine 60 Fasting plasma glucose 60 blood urea nitrogen 60 tirofiban 60 INFERGEN 60 serum PTH 60 plus prednisone prednisolone 60 p = #.# [003] 60 mg kg dose 60 IDDM 60 LDL HDL 60 PREZISTA r 60 fibrin deposition 60 pyrexia mucositis sepsis febrile 60 Left Ventricular Ejection Fraction 60 multiple logistic regression 60 receiving XGEVA 60 pyridostigmine 60 inhibin B 60 achieved CCyR 60 prospectively defined 60 liver transplant recipients 60 mcg mL 60 alkaline phosphatase ALP 60 hemoglobin A1c 60 cerebral perfusion 60 FOLPI regimen 60 urine NGAL 60 pressure tachycardia diaphoresis 60 standard chemotherapy regimen 60 dose atorvastatin 60 mIU ml 60 q#h 60 reintubation 60 -#.# mg dL [001] 60 Arrhythmogenic 60 mmHg systolic 60 recurrent glioblastoma multiforme 60 Decompensated Heart Failure 60 TIMP 1 60 mcg BID 60 CCyR 60 nasal symptom 60 cytologic 60 nmol l 60 #mg BID [003] 60 x ULN 60 apnea hypopnea index 60 leucopenia 60 fasting lipid 60 proteinuria 60 Prospective Randomized 60 Nonalcoholic Fatty Liver Disease 60 anti coagulant therapy 60 unresectable HCC 60 ventricular tachyarrhythmia 60 blood glucose concentrations 60 tapentadol ER 60 glycemia 60 salivary flow 60 TEAEs 60 Alanine 60 MDS MPD 60 clinically meaningful reductions 60 multivariate Cox 60 ug dose 60 Atomoxetine 60 bioavailable testosterone 60 8 OHdG 60 extrapyramidal symptoms 60 LVNC 60 FOLFOX6 60 ACE Inhibitor 60 transabdominal 60 AVANDIA 60 adalimumab Humira 60 bolus dose 60 serum magnesium 60 timepoint 60 % Confidence Interval 60 mean serum phosphorus 60 Severity Index PASI 60 upper endoscopies 60 hemodynamic measurements 60 foveal thickness 60 anemia hemoglobin 60 Unstable Angina 60 -# dBc typical 60 transcranial Doppler 60 Prostate Specific Antigen 60 Prostate Specific Antigen PSA 60 electrophysiologic 60 mL kg 60 gout flares 60 gadobutrol 60 SCr 60 dose titration 60 transaminase elevations 60 -#.# ± [002] 60 CI -#.# 60 trastuzumab Herceptin ® 60 valvular disease 60 HIV RNA 60 diagnostic angiography 60 cytogenetic response 60 squamous intraepithelial lesions 60 J Am Coll 60 artery occlusion 60 Hemoglobin A1C 60 nondiabetic patients 60 DLQI 60 metformin sulfonylurea 60 myocardial necrosis 60 IFN beta 60 nephrotoxicity 60 leukocyte count 60 Lupuzor ™ 60 arterial thromboembolic events 60 NIHSS score 60 electrical cardioversion 60 baseline FEV 60 hemorrhagic complications 60 glulisine 60 receiving immunosuppressive therapy 60 Hospitalized Patients 60 Ileus 60 rFSH 60 intracranial hemorrhage ICH 60 postmenopausal osteoporotic women 60 #mg dose [002] 60 LV dysfunction 60 mixed hyperlipidemia 60 preserved ejection fraction 60 Available Seat Kilometres ASKs 60 hepatic cirrhosis 60 nonfasting 60 Myocardial Ischemia 60 Lipid Levels 60 Lymphocytic 60 Cmax 60 choline intake 60 μg L 60 multivariate analyzes 60 quantitative coronary angiography 60 deCODE AF TM 60 #mg BID [001] 60 folate vitamin B6 60 NSTE ACS 60 hyperoxia 60 Fecal occult blood 60 oral FTY# 60 galiximab 60 SRBD 60 nadolol 60 hypocalcemia 60 pharmacologic stress 60 albuminuria 60 complete cytogenetic response 60 cystatin C 60 hMG 60 Androgen Deprivation Therapy 60 antidiabetic medication 60 #.#g/day 60 perioperative mortality 60 peg interferon 60 thyrotropin 60 hemodynamically significant 60 mesalamine granules 60 diastolic blood pressures 60 carotid revascularization 60 pelvic ultrasound 60 plasma pharmacokinetics 60 inhaled budesonide 60 ARCALYST ® 60 vincristine doxorubicin 60 perioperative morbidity 60 dose proportionality 60 Contraindications 60 Eur Arch 60 sensitivity specificity 60 plasma leptin 60 R0 resection 60 6mg 60 endometrial biopsy 60 clinicopathological features 60 IBDQ 60 multivariable analyzes 60 IELT 60 BEXXAR Therapeutic Regimen 60 potassium sparing diuretics 60 placebo PBO 60 esophageal acid 60 REYATAZ r arm 60 semiquantitative 60 #dhTxB# 60 airway hyperresponsiveness 60 nephrectomy 60 serum LDL cholesterol 60 noninvasively measures 60 valsartan amlodipine 60 serum sodium concentration 60 Meta analyzes 60 recurrent VTE 60 concomitant antibiotics 60 â ‰ ¥ 60 Cream USP 1 60 adenoma recurrence 60 6MWD 60 HbA1c levels 60 Hormone Refractory Prostate Cancer 60 posaconazole 60 Bronchial Thermoplasty 60 Endothelial dysfunction 60 Decitabine 60 ertapenem 60 International Normalized Ratio 60 OPT CHF 60 Tumor shrinkage 60 MAGE A3 ASCI 60 Renal Cell Carcinoma RCC 60 beta blocker therapy 60 IU mL 60 adiponectin concentrations 60 alfuzosin 60 Homocysteine levels 60 VCUG 60 Main Outcome Measure 60 serum phosphorus levels 60 Renal dysfunction 60 clinically meaningful improvement 60 maximally tolerated dose 60 serum chemistries should 60 Unified Parkinson Disease 60 TNF antagonist 60 eGFR 60 antihypertensive medications 60 adrenalectomy 60 serum antibody 60 VIIBRYD 60 Aeolus Pharmaceuticals Announces 60 3mg/kg 60 Coronary artery bypass grafting 60 Hamilton Anxiety Scale 60 Carotid Revascularization Endarterectomy vs. 60 placebo dexamethasone 60 HER2 overexpression 60 Kaplan Meier estimates 60 Nesiritide 60 Cardiac Resynchronization 60 antimuscarinic 60 insulin secretagogue 60 polyp detection 60 MCyR 60 Arch Intern Med 60 bFGF 60 TNF Tumor Necrosis Factor 60 primary hypercholesterolemia 60 immunohistochemical 59 reactogenicity 59 accompanying electrolyte abnormalities 59 lipid lowering medication 59 aplastic anemia AA 59 5 Fluorouracil 59 cytogenic 59 triglycerides TG 59 mm Hg systolic 59 Kidney Disease Outcomes 59 BARACLUDE ® 59 thrombocytosis 59 headache abdominal pain 59 titrated glipizide 59 Eur J Endocrinol 59 #.#mmol L [001] 59 lymphocyte counts 59 human Chorionic Gonadotropin 59 EEG abnormalities